Bruno Vandelanotte is a seasoned medical technology professional with more than 40 years of international experience in sales, business development, and market introduction of innovative medical devices. In his role as Sales Manager EMEA at Roncadelle Operations, he drives the commercialization of the SafeR® safety syringe and needle portfolio across Europe, the Middle East, and Africa.
He has built his career with global companies in radiology, cardiology, and infection prevention, focusing on bringing cutting-edge solutions to healthcare systems, hospitals, and humanitarian organizations. In addition, Bruno is the founder and CEO of VanMed Consulting in Belgium, where he advises on market access, distribution, and clinical collaborations for next-generation medical technologies.
At the World Vaccine Congress, Bruno will highlight how SafeR® syringes and needles eliminate needle-stick injuries, reduce medical waste, and support sustainable vaccination campaigns worldwidex
12:40 - TITLE TBCDr Benjamin Damien , CEO, Sagitta Biotech
12:45 - 'Comprehensive Immunopeptidomics Platform for Vaccine Development and Construct Validation'Dr Elise Pepermans, CEO, ImmuneSpec
12:50 - TITLE TBCDr Vanessa Vankerckhoven, CEO, Idevax
12:55 - 'eFIT: A novel electron beam platform for Vaccine Manufacturing'Daniel Becker, Head of Business Development, KyooBe Tech
13:00 - 'SafeR® Syringes — Engineering Safety and Sustainability'Bruno Vandelanotte, Head of EMEA Sales, Roncadelle Operations
13:05 - 'Unlocking Scalable Biomanufacturing for Advanced Therapies'Dirk Hahneiser, General Manager, Cocoon Bioscience
13:10 - TITLE TBCMarkus Mandler, CEO & Founder, Tridem Bioscience
13:15 - Start-Up Pitch Feedback Panel